Selivanova G - Search Results

1

Inhibition of p53 inhibitors: progress, challenges and perspectives.

Sanz G, Singh M, Peuget S, Selivanova G. Sanz G, et al. Among authors: selivanova g. J Mol Cell Biol. 2019 Jul 19;11(7):586-599. doi: 10.1093/jmcb/mjz075. J Mol Cell Biol. 2019. PMID: 31310659 Free PMC article. Review.

2

Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain.

Selivanova G, Iotsova V, Okan I, Fritsche M, Ström M, Groner B, Grafström RC, Wiman KG. Selivanova G, et al. Nat Med. 1997 Jun;3(6):632-8. doi: 10.1038/nm0697-632. Nat Med. 1997. PMID: 9176489

3

Reactivation of mutant p53: a new strategy for cancer therapy.

Selivanova G, Kawasaki T, Ryabchenko L, Wiman KG. Selivanova G, et al. Semin Cancer Biol. 1998;8(5):369-78. doi: 10.1006/scbi.1998.0099. Semin Cancer Biol. 1998. PMID: 10101802 Review.

4

Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain.

Selivanova G, Ryabchenko L, Jansson E, Iotsova V, Wiman KG. Selivanova G, et al. Mol Cell Biol. 1999 May;19(5):3395-402. doi: 10.1128/MCB.19.5.3395. Mol Cell Biol. 1999. PMID: 10207063 Free PMC article.

A synthetic 22-mer peptide (peptide 46) derived from the p53 C-terminal domain can restore the growth suppressor function of mutant p53 proteins in human tumor cells (G. Selivanova et al., Nat. Med. 3:632-638, 1997). Here we demonstrate that peptide 46 binds mutant …

A synthetic 22-mer peptide (peptide 46) derived from the p53 C-terminal domain can restore the growth suppressor function of mutant p53 prot …

5

Inactivation of Myc-induced p53-dependent apoptosis in human tumors.

Henriksson M, Selivanova G, Lindström M, Wiman KG. Henriksson M, et al. Among authors: selivanova g. Apoptosis. 2001 Feb-Apr;6(1-2):133-7. doi: 10.1023/a:1009644716727. Apoptosis. 2001. PMID: 11321036 Review.

6

p53 induction as an indicator of DNA damage.

Selivanova G. Selivanova G. Methods Mol Biol. 2002;203:279-88. doi: 10.1385/1-59259-179-5:279. Methods Mol Biol. 2002. PMID: 12073449 No abstract available.

7

Inhibition of p53 activity in vitro and in living cells by a synthetic peptide derived from its core domain.

Protopopova M, Selivanova G. Protopopova M, et al. Among authors: selivanova g. Cell Cycle. 2003 Nov-Dec;2(6):592-5. Cell Cycle. 2003. PMID: 14504475

8

p53: fighting cancer.

Selivanova G. Selivanova G. Curr Cancer Drug Targets. 2004 Aug;4(5):385-402. doi: 10.2174/1568009043332934. Curr Cancer Drug Targets. 2004. PMID: 15320716 Review.

9

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

Issaeva N, Bozko P, Enge M, Protopopova M, Verhoef LG, Masucci M, Pramanik A, Selivanova G. Issaeva N, et al. Among authors: selivanova g. Nat Med. 2004 Dec;10(12):1321-8. doi: 10.1038/nm1146. Epub 2004 Nov 21. Nat Med. 2004. PMID: 15558054

10

Reactivation of mutant p53: molecular mechanisms and therapeutic potential.

Selivanova G, Wiman KG. Selivanova G, et al. Oncogene. 2007 Apr 2;26(15):2243-54. doi: 10.1038/sj.onc.1210295. Oncogene. 2007. PMID: 17401433 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page